The EIIS team are excited to announce that Xeolas Pharmaceuticals, the DCU-campus based company has secured investment of €1.3 million from its’ investors. The innovative pharma business has obtained €1.1 million from The Goodbody 2018 EIIS Fund managed by Baker Tilly and Goodbody, and a further €250 thousand from private EIIS investors. The private investors […]
